Retractable Technologies, Inc. (RVP)
NYSEAMERICAN: RVP · Real-Time Price · USD
0.640
+0.017 (2.75%)
Dec 20, 2024, 4:00 PM EST - Market closed
Retractable Technologies Revenue
Retractable Technologies had revenue of $10.35M in the quarter ending September 30, 2024, with 0.11% growth. This brings the company's revenue in the last twelve months to $38.27M, down -8.86% year-over-year. In the year 2023, Retractable Technologies had annual revenue of $43.60M, down -54.02%.
Revenue (ttm)
$38.27M
Revenue Growth
-8.86%
P/S Ratio
0.50
Revenue / Employee
$253,411
Employees
151
Market Cap
19.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 43.60M | -51.22M | -54.02% |
| Dec 31, 2022 | 94.82M | -93.56M | -49.67% |
| Dec 31, 2021 | 188.38M | 106.52M | 130.12% |
| Dec 31, 2020 | 81.86M | 40.07M | 95.86% |
| Dec 31, 2019 | 41.80M | 8.52M | 25.61% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Concord Medical Services Holdings | 64.91M |
| Bionano Genomics | 33.33M |
| BioLineRx | 21.99M |
| CervoMed | 10.07M |
| Bolt Biotherapeutics | 9.78M |
| Affimed | 6.29M |
| HCW Biologics | 3.50M |
| Palatin Technologies | 2.38M |
RVP News
- 5 weeks ago - Retractable Technologies, Inc. Results for the Periods Ended September 30, 2024 - Business Wire
- 2 months ago - Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders - Business Wire
- 2 months ago - Retractable Technologies, Inc. Files Complaint in United States Court of International Trade - Business Wire
- 3 months ago - Tariffs Finalized on Chinese Imports - Business Wire
- 4 months ago - Retractable Technologies, Inc. Results for the Periods Ended June 30, 2024 - Business Wire
- 7 months ago - Retractable Technologies, Inc. Results for the Period Ended March 31, 2024 - Business Wire
- 9 months ago - Retractable Technologies, Inc. Reports Results for 2023 - Business Wire
- 1 year ago - Retractable Technologies, Inc. Not Impacted by FDA Safety Communication - Business Wire